Publication

hENT1 RNA and protein in combination may act as predictive biomarkers for survival for patients treated with adjuvant gemcitabine in pancreatic cancer

Hale, J
; 
Evans, A
; 
Aughton, K
; 
Elander, NO
; 
Ghaneh, P
; 
Neoptolemos, JP
; 
Jackson, R
; 
Cox, TF
; 
Campbell, F
; 
Halloran, CM
... show 10 more
Citations
Altmetric:
Abstract
Authors
Hale, J
Evans, A
Aughton, K
Elander, NO
Ghaneh, P
Neoptolemos, JP
Jackson, R
Cox, TF
Campbell, F
Halloran, CM
Mackey, JR
Scarfe, AG
Valle, Juan W
Carter, R
Cunningham, D
Tebbutt, NC
Goldstein, D
Shannon, J
Glimelius, B
Deakin, M
Charnley, RM
Anthoney, A
Lerch, MM
Mayerle, J
Costello, E
Palmer, DH
Buchler, MW
Greenhalf, W
Affiliation
Liverpool Cancer Trials Unit, University of Liverpool, Liverpool,
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Hale J, Evans A, Aughton K, Elander N, Ghaneh P, Neoptolemos J, et al. hENT1 RNA and protein in combination may act as predictive biomarkers for survival for patients treated with adjuvant gemcitabine in pancreatic cancer. Pancreas. 2019;48(10):1436-7
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622693
Embedded videos